MECP2 and atypical Rett syndrome: Very recently, it has been demonstrated that a mutation in squalene synthesis was found by randomly mutating a second genomic site in Mecp2-mutant mice, which was able to increase life span and decrease other RTT-like symptoms (Communication by Justice M, at 7th World Congress on Rett Syndrome, New Orleans, 2012).